ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120103HealthcareUS1 holder
Total Value
$1.77M
Total Shares
3.21M
Net Share Change
+1.83M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$1.77M3.21M shares
ADD+1.83M(+131.9%)